Suppr超能文献

增强理性蛋白质工程以降低高浓度IgG1抗体溶液的粘度

Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutions.

作者信息

Lefevre Tyler J, Caldwell Jenna G, Gallegos Austin, Du Qun, Houston Erin, Kaplan Gilad, Esfandiary Reza

机构信息

Dosage Form Design & Development, Biopharmaceutical Development, R&D, AstraZeneca, Gaithersburg, USA.

Biologics Engineering, R&D, AstraZeneca, Gaithersburg, USA.

出版信息

MAbs. 2025 Dec;17(1):2543771. doi: 10.1080/19420862.2025.2543771. Epub 2025 Aug 8.

Abstract

Subcutaneous (SC) delivery of therapeutic antibodies can offer multiple benefits to patients and healthcare providers, including convenience, time savings, and cost reduction. To improve the SC injection experience, drug developers may seek a low injection volume (1-2 mL), which for some antibody drugs necessitates a high concentration solution (≥100 mg/mL) to meet dosage requirements. Several molecular-level challenges hinder the development of high concentration antibody drug products, including high viscosity caused by reversible self-association (RSA). Here, we take an enhanced rational design approach to reduce RSA via protein engineering. Using hydrogen-deuterium exchange mass spectrometry (HDX-MS), we identified potential self-interaction hotspots on the surface of an in-house IgG1 which has known viscosity issues at high concentration. Then, using antibody modeling, we identified sites near the complementary-determining regions for targeting by rational mutagenesis, which included predicted patches of charge or hydrophobicity within or near peptides highlighted by HDX-MS. Screening of nearly 70 variants using dynamic light scattering (DLS) and affinity capture self-interaction nanospectroscopy (AC-SINS) at low concentration showed decreased self-interaction in many variants. Viscosity at 150 mg/mL was reduced by 70% for 13 variants, while two of these variants designed to reduce surface hydrophobicity were found to retain antigen binding compared to the parent antibody. DLS and AC-SINS measurements of self-association were found to correlate with viscosity at high concentration, reinforcing their utility as effective low-concentration screening tools for viscosity. This work demonstrates an enhanced rational mutagenesis strategy informed by the combination of HDX-MS for self-association and predictions of surface properties. The resulting variants are a vast improvement on the parent antibody's viscosity issues and offer insight into the mechanism of self-association.

摘要

皮下(SC)注射治疗性抗体可为患者和医疗服务提供者带来诸多益处,包括便利性、节省时间和降低成本。为改善皮下注射体验,药物研发人员可能会寻求低注射体积(1-2毫升),对于某些抗体药物而言,这就需要高浓度溶液(≥100毫克/毫升)以满足剂量要求。若干分子层面的挑战阻碍了高浓度抗体药物产品的研发,其中包括可逆自缔合(RSA)导致的高粘度。在此,我们采用一种强化的理性设计方法,通过蛋白质工程来降低RSA。利用氢-氘交换质谱(HDX-MS),我们在一种内部IgG1的表面鉴定出潜在的自相互作用热点,该IgG1在高浓度时存在已知的粘度问题。然后,通过抗体建模,我们确定了互补决定区附近的位点,以便通过理性诱变进行靶向,其中包括HDX-MS突出显示的肽段内部或附近预测的电荷或疏水性斑块。在低浓度下使用动态光散射(DLS)和亲和捕获自相互作用纳米光谱(AC-SINS)对近70个变体进行筛选,结果显示许多变体的自相互作用有所降低。13个变体在150毫克/毫升时的粘度降低了70%,而与亲本抗体相比,其中两个旨在降低表面疏水性的变体被发现保留了抗原结合能力。发现DLS和AC-SINS的自缔合测量结果与高浓度下粘度相关联,这增强了它们作为粘度有效低浓度筛选工具的效用。这项工作展示了一种强化的理性诱变策略,该策略由用于自缔合的HDX-MS和表面性质预测相结合而得出。所得变体在亲本抗体的粘度问题上有了极大改善,并为自缔合机制提供了见解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验